Free quarterly webinars and paid CME-accredited deep-dives for clinicians, investigators, and clinical research professionals — covering oncology evidence, trial methodology, and regulatory practice.
All upcoming sessions are free to attend. Registration is required — places are limited to 150 participants per session.
A practical review of FDA 21 CFR Part 50 requirements, common consent process failures identified in FDA Warning Letters, and how sites can build consent conversations that are genuinely patient-centred and audit-ready.
A practical look at biospecimen collection protocols in Phase I/II oncology trials — specimen types, cold-chain requirements, central laboratory coordination, and how biomarker data shapes trial outcomes and regulatory submissions.
Extended sessions with slides, Q&A transcripts, and supplementary reading. Available for purchase individually or as an annual bundle.
90-minute session covering documentation, safety reporting, protocol deviations, and audit preparation — with worked examples from FDA inspection findings.
A methodologist's guide to pre-specification, handling multiplicity, and writing SAPs that FDA reviewers and journal editors find acceptable — with annotated examples.
How to select, validate, and incorporate biomarkers into oncology trial design — covering predictive vs. prognostic markers, co-development, and FDA's Biomarker Qualification Program.
Full archive of past recordings, priority registration for all live sessions, and exclusive Q&A access with the KCLG Medical research team.
We announce new webinar dates and recordings by email — typically 6 weeks in advance. Join the list to secure early-bird registration.
No spam. Unsubscribe any time. See our Privacy Policy.